China’s biotech surge sparks US security concerns as drug trials break records in 2025 (opens original article in a new tab)

China's clinical drug trial registrations hit a record 5,215 in 2025, with most trials focused on cancer treatments and initiated by domestic companies.

• Clinical drug trial registrations in China reached a record 5,215 in 2025.
• 93% of trials were initiated or funded by Chinese companies and institutions.
• Cancer treatments were the most common focus of new drug trials.